SleepioRx v1
SleepioRx v1 is a mental health/function therapeutic software (FDA Class II; FDA product code QVO, Computerized Behavioral Therapy Device For Insomnia) made by Big Health, Inc., cleared under FDA 510(k) K233577 on 5 Aug 2024 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 00860008033024), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00860008033024 | Date14 Mar 2025 | StatusListed |
| United States | FDA 510(k)SESE | NumberK233577 | Date5 Aug 2024 | StatusActive |
Official records
- AccessGUDID record 00860008033024
- FDA 510(k) database K233577
From the FDA record
- Device description
- SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia / insomnia disorder as an adjunct to usual care in patients aged 18 and older. SleepioRx is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K233577 decided 5 Aug 2024 Active
- FDA GUDID UDI-DI 00860008033024 listed 14 Mar 2025 Listed
Timeline
- Cleared FDA 510(k) K233577
- Listed FDA GUDID 00860008033024
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- SleepioRx
- Generic name
- Mental health/function therapeutic software, screen-viewed
- Model / reference
- v1
- Primary DI / UDI-DI
- 00860008033024
- 510(k) Number
- FDA product code
- QVO
- GMDN term
- Mental health/function therapeutic software, screen-viewed
- Device class
- Class II
- Regulation number
- 882.5801
- GUDID distribution status
- In Commercial Distribution